MCE - Delayed Quote EUR
Grifols, S.A. (GRF.MC)
8.62
-0.31
(-3.51%)
At close: 5:41:05 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
902,168
902,168
218,690
-1,427
596,975
Investing Cash Flow
886,667
886,667
-394,719
-1,996,123
-854,149
Financing Cash Flow
-1,358,714
-1,358,714
171,493
-164,901
2,297,679
End Cash Position
979,780
979,780
529,577
549,207
2,675,611
Capital Expenditure
-371,367
-371,367
-310,320
-392,872
-315,088
Repayment of Debt
-111,488
-111,488
-116,394
-104,287
-82,692
Repurchase of Capital Stock
0
0
0
-3,459
-125,703
Free Cash Flow
530,801
530,801
-91,630
-394,299
281,887
12/31/2021 - 5/17/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BAYN.DE Bayer Aktiengesellschaft
22.17
-10.39%
NOV.DE Novo Nordisk A/S
57.91
-1.09%
SAN.PA Sanofi
88.84
-0.97%
LLY.DE Eli Lilly and Company
647.90
-3.60%
RO.SW Roche Holding AG
268.80
-1.68%
NOVN.SW Novartis AG
89.34
-0.84%
BAYRY Bayer Aktiengesellschaft
6.23
-10.09%
SNW.DE Sanofi
88.83
-1.31%
SNW.HM Sanofi SA
88.76
-1.15%
ROG.SW Roche Holding AG
254.50
-1.74%